Literature DB >> 19012471

Prevalence, risk factors, and clinical features of thyroid-associated ophthalmopathy in multiethnic Malaysian patients with Graves' disease.

Shueh Lin Lim1, Andrew Keat Eu Lim, Malik Mumtaz, Elias Hussein, Wan Mohamad Wan Bebakar, Amir S Khir.   

Abstract

BACKGROUND: The prevalence of thyroid-associated ophthalmopathy (TAO) has been reported to be lower in several Asian populations than in Caucasians. The risk factors for TAO that have been demonstrated in Caucasians have not been studied in Asian populations. The aim of this study, therefore, was to determine the prevalence, risk factors, and clinical features of TAO in a cohort of multiethnic Malaysian patients with Graves' disease (GD).
METHODS: This was a cross-sectional study of 167 consecutive patients with GD who attended two endocrine clinics from October 2003 to September 2004. The patients were classified as Malay, Chinese, and Indian based on their ethnic characteristics as detailed in the national identity card. The patients were examined by a single individual for the presence and characteristics of TAO. Thyroid function tests were performed, and smoking history and the extent of smoking history were recorded.
RESULTS: The prevalence rate of TAO using the American Academy of Ophthalmology diagnostic criteria was 34.7%. This increased to 46.7% if lower lid retraction was added as an alternate criterion. The observed prevalence rate was higher than expected in the Chinese patient population based on a comparison with the Malay and Indian patients, but this was not statistically significant. Smokers with GD were at 2.75 times greater risk of TAO than nonsmokers (p = 0.019). Male gender was shown to confer higher risk of TAO on univariate analysis (p = 0.003), but not on multivariate analysis. The percentage of males who smoked in the study group was relatively high (79%). The most common presentation of TAO was exophthalmos, followed by lid retraction.
CONCLUSIONS: TAO has relatively high prevalence rate (34.7%) in three populations of Asian patients with GD. This is similar to that reported for Caucasian patients with GD. As in Caucasian patients, smoking increases the risk of TAO. In the Asian populations we studied, exophthalmos was the most common eye sign. However, lower lid retraction was also common and present in 60% of cases with other signs of TAO. In Chinese, Malay, and Indian Asians with GD, lower lid retraction should be a diagnostic criterion for TAO.

Entities:  

Mesh:

Year:  2008        PMID: 19012471     DOI: 10.1089/thy.2008.0044

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  30 in total

Review 1.  Current concepts in the molecular pathogenesis of thyroid-associated ophthalmopathy.

Authors:  Yao Wang; Terry J Smith
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-03-20       Impact factor: 4.799

Review 2.  Risk factors for development or deterioration of Graves' ophthalmopathy.

Authors:  Marius N Stan; Rebecca S Bahn
Journal:  Thyroid       Date:  2010-07       Impact factor: 6.568

Review 3.  Thyroid associated ophthalmopathy - a review.

Authors:  Ps Mallika; Ak Tan; S Aziz; Sar Syed Alwi; Ms Chong; R Vanitha; G Intan
Journal:  Malays Fam Physician       Date:  2009-04-30

Review 4.  The risk factors for Graves' ophthalmopathy.

Authors:  Jiamin Cao; Yuhe Su; Zhuokun Chen; Chen Ma; Wei Xiong
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-11-17       Impact factor: 3.117

5.  Doxycycline vs Placebo at 12 Weeks in Patients With Mild Thyroid-Associated Ophthalmopathy: A Randomized Clinical Trial.

Authors:  Yuan Pan; Yu-Xi Chen; Jian Zhang; Miao-Li Lin; Guang-Ming Liu; Xue-Liang Xu; Xian-Qun Fan; Yong Zhong; Qing Li; Si-Ming Ai; Wen Xu; Jia Tan; Hui-Fang Zhou; Dong-Dong Xu; Hui-Ying Zhang; Bei Xu; Sha Wang; Jun-Jie Ma; Shuo Zhang; Lin-Yang Gan; Jian-Tao Cui; Li Li; Yan-Yan Xie; Xinxing Guo; Nathan Pan-Doh; Zhuo-Ting Zhu; Yao Lu; Yu-Xun Shi; Yi-Wen Xia; Zuo-Yi Li; Dan Liang
Journal:  JAMA Ophthalmol       Date:  2022-09-29       Impact factor: 8.253

Review 6.  Prevalence and natural history of Graves' orbitopathy in the XXI century.

Authors:  E Piantanida; M L Tanda; A Lai; L Sassi; L Bartalena
Journal:  J Endocrinol Invest       Date:  2013-04-16       Impact factor: 4.256

7.  Toll-like receptor gene polymorphisms are associated with susceptibility to Graves' ophthalmopathy in Taiwan males.

Authors:  Wen-Ling Liao; Rong-Hsing Chen; Hui-Ju Lin; Yu-Huei Liu; Wen-Chi Chen; Yuhsin Tsai; Lei Wan; Fuu-Jen Tsai
Journal:  BMC Med Genet       Date:  2010-11-05       Impact factor: 2.103

8.  Radioiodine I-131 for the therapy of graves' disease.

Authors:  Malik Mumtaz; Lim Shueh Lin; Khaw Chong Hui; Amir Sharifuddin Mohd Khir
Journal:  Malays J Med Sci       Date:  2009-01

9.  Age differences in clinical manifestation and prognosis of thyroid eye disease.

Authors:  Guy J Ben Simon; Gabriel Katz; Ofira Zloto; Hana Leiba; Beatrix Hadas; Ruth Huna-Baron
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-09-07       Impact factor: 3.117

10.  Biometric and refractive changes after orbital decompression in Korean patients with thyroid-associated orbitopathy.

Authors:  W S Kim; Y S Chun; B Y Cho; J K Lee
Journal:  Eye (Lond)       Date:  2015-11-20       Impact factor: 3.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.